252 related articles for article (PubMed ID: 30703546)
21. Effects of meals on gastric emptying and small intestinal transit times of a suspension in the beagle dog assessed using acetaminophen and salicylazosulfapyridine as markers.
Mizuta H; Kawazoe Y; Haga K; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2224-7. PubMed ID: 1980638
[TBL] [Abstract][Full Text] [Related]
22. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.
Sagara K; Nagamatsu Y; Yamada I; Kawata M; Mizuta H; Ogawa K
Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3303-6. PubMed ID: 1294333
[TBL] [Abstract][Full Text] [Related]
23. A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.
Abuhelwa AY; Foster DJR; Upton RN
AAPS J; 2016 Sep; 18(5):1322-1333. PubMed ID: 27439620
[TBL] [Abstract][Full Text] [Related]
24. Wireless Monitoring of Gastrointestinal Transit Time, Intra-luminal pH, Pressure and Temperature in Experimental Pigs: A Pilot Study.
Bureš J; Radochová V; Květina J; Kohoutová D; Vališ M; Rejchrt S; Žďárová Karasová J; Soukup O; Suchánek Š; Zavoral M
Acta Medica (Hradec Kralove); 2023; 66(1):11-18. PubMed ID: 37384804
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.
Lubach JW; Chen JZ; Hau J; Imperio J; Coraggio M; Liu L; Wong H
Mol Pharm; 2013 Nov; 10(11):3997-4004. PubMed ID: 23961831
[TBL] [Abstract][Full Text] [Related]
26. Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state.
Schneider F; Grimm M; Koziolek M; Modeß C; Dokter A; Roustom T; Siegmund W; Weitschies W
Eur J Pharm Biopharm; 2016 Nov; 108():214-219. PubMed ID: 27639346
[TBL] [Abstract][Full Text] [Related]
27. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Kuentz M; Nick S; Parrott N; Röthlisberger D
Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
[TBL] [Abstract][Full Text] [Related]
28. Gastric pH profiles of beagle dogs and their use as an alternative to human testing.
Akimoto M; Nagahata N; Furuya A; Fukushima K; Higuchi S; Suwa T
Eur J Pharm Biopharm; 2000 Mar; 49(2):99-102. PubMed ID: 10704891
[TBL] [Abstract][Full Text] [Related]
29. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.
Pang J; Dalziel G; Dean B; Ware JA; Salphati L
Mol Pharm; 2013 Nov; 10(11):4024-31. PubMed ID: 23980865
[TBL] [Abstract][Full Text] [Related]
31. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
32. Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers.
Haruta S; Kawai K; Nishii R; Jinnouchi S; Ogawara Ki; Higaki K; Tamura S; Arimori K; Kimura T
Int J Pharm; 2002 Feb; 233(1-2):179-90. PubMed ID: 11897422
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy.
Haruta S; Kawai K; Jinnouchi S; Ogawara KI; Higaki K; Tamura S; Arimori K; Kimura T
J Pharm Sci; 2001 Apr; 90(4):464-73. PubMed ID: 11170036
[TBL] [Abstract][Full Text] [Related]
34. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog.
Parr AF; Sandefer EP; Wissel P; McCartney M; McClain C; Ryo UY; Digenis GA
Pharm Res; 1999 Feb; 16(2):266-71. PubMed ID: 10100313
[TBL] [Abstract][Full Text] [Related]
36. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption.
Oswald H; Sharkey M; Pade D; Martinez MN
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):192-203. PubMed ID: 26409436
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
[TBL] [Abstract][Full Text] [Related]
38. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
[TBL] [Abstract][Full Text] [Related]
39. Excipient effects on gastrointestinal transit and drug absorption in beagle dogs.
Schulze JD; Peters EE; Vickers AW; Staton JS; Coffin MD; Parsons GE; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):67-75. PubMed ID: 15979264
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.
Sequeira IR; Lentle RG; Kruger MC; Hurst RD
PLoS One; 2015; 10(12):e0143690. PubMed ID: 26629926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
